{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:03:04Z","timestamp":1791331384209,"version":"4.3.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.neulet.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T19:04:18Z","timestamp":1428260658000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis"],"prefix":"10.1016","volume":"595","author":[{"given":"Weisi","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley K.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2015.04.002_bib0005","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.spinee.2010.08.015","article-title":"Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain","volume":"10","author":"Ahmed","year":"2010","journal-title":"Spine J.: Off. J. N. Am. Spine Soc."},{"key":"10.1016\/j.neulet.2015.04.002_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainresrev.2008.12.003","article-title":"Targeting CB2 receptors and the endocannabinoid system for the treatment of pain","volume":"60","author":"Anand","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neulet.2015.04.002_bib0015","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1460-9568.2006.04684.x","article-title":"CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms","volume":"23","author":"Beltramo","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2015.04.002_bib0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroscience.2011.12.028","article-title":"Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury","volume":"203","author":"Brownjohn","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2015.04.002_bib0025","doi-asserted-by":"crossref","first-page":"e80440","DOI":"10.1371\/journal.pone.0080440","article-title":"Cannabinoid CB2 receptors regulate central sensitization and pain responses associated with osteoarthritis of the knee joint","volume":"8","author":"Burston","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2015.04.002_bib0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejphar.2011.06.057","article-title":"Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice","volume":"668","author":"Curto-Reyes","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0035","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.pain.2011.04.005","article-title":"Activation of cannabinoid receptors by the pentacyclic triterpene alpha, beta-amyrin inhibits inflammatory and neuropathic persistent pain in mice","volume":"152","author":"da Silva","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2015.04.002_bib0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2012.08.008","article-title":"Effects of se-phenyl thiazolidine-4-carboselenoate on mechanical and thermal hyperalgesia in brachial plexus avulsion in mice: mediation by cannabinoid CB1 and CB2 receptors","volume":"1475","author":"Del Fabbro","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2015.04.002_bib0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neuropharm.2013.10.006","article-title":"Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors","volume":"77","author":"Desroches","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2015.04.002_bib0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pain.2005.09.005","article-title":"Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat","volume":"118","author":"Elmes","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2015.04.002_bib0055","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0169-409X(03)00101-7","article-title":"Spinal delivery of analgesics in experimental models of pain and analgesia","volume":"55","author":"Fairbanks","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neulet.2015.04.002_bib0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.pain.2012.12.002","article-title":"Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis","volume":"154","author":"Foley","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2015.04.002_bib0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-8069-9-32","article-title":"Analgesic effect of a mixed T-type channel inhibitor\/CB2 receptor agonist","volume":"9","author":"Gadotti","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neulet.2015.04.002_bib0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.sc.3101982","article-title":"The treatment of spasticity with delta9 \u2013 tetrahydrocannabinol in persons with spinal cord injury","volume":"45","author":"Hagenbach","year":"2007","journal-title":"Spinal Cord"},{"key":"10.1016\/j.neulet.2015.04.002_bib0075","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.neuropharm.2009.12.010","article-title":"Cannabinoid receptor\u2013mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain","volume":"58","author":"Hama","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2015.04.002_bib0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.169.1.117","article-title":"Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund\u2019s adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells","volume":"169","author":"Hofstetter","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0085","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/S0968-0896(99)00219-9","article-title":"3-(1\u2032,1\u2032-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor","volume":"7","author":"Huffman","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neulet.2015.04.002_bib0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/7854_2014_288","article-title":"Mechanisms and pharmacology of neuropathic pain in multiple sclerosis","volume":"20","author":"Iannitti","year":"2014","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neulet.2015.04.002_bib0095","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neuroscience.2013.07.040","article-title":"Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice","volume":"250","author":"Ikeda","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2015.04.002_bib0100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/FBP.0b013e3282f00c10","article-title":"Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice","volume":"18","author":"Jafari","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0105","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuropharm.2010.07.015","article-title":"The cannabinoid 1 receptor antagonist AM251 produces nocifensive behavior via activation of ERK signaling pathway","volume":"59","author":"Katsuyama","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2015.04.002_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2013.11.002","article-title":"Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS","volume":"287","author":"Kong","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0115","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jpain.2012.05.013","article-title":"Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain","volume":"13","author":"Landry","year":"2012","journal-title":"J. Pain: Off. J. Am. Pain Soc."},{"key":"10.1016\/j.neulet.2015.04.002_bib0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.molimm.2011.09.016","article-title":"Targeting CB2 receptor as a neuroinflammatory modulator in experimental autoimmune encephalomyelitis","volume":"49","author":"Lou","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1471-4892(02)00004-8","article-title":"CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?","volume":"3","author":"Malan","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm1561","article-title":"Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells","volume":"13","author":"Maresz","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2015.04.002_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02190083","article-title":"Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial","volume":"240","author":"Maurer","year":"1990","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neulet.2015.04.002_bib0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2015.04.002_bib0145","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1179\/1743132812Y.0000000082","article-title":"Multiple sclerosis and pain","volume":"34","author":"Nick","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neulet.2015.04.002_bib0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2008.11.002","article-title":"Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE)","volume":"141","author":"Olechowski","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2015.04.002_bib0155","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejpain.2004.11.005","article-title":"Central pain in multiple sclerosis\u2013prevalence and clinical characteristics","volume":"9","author":"Osterberg","year":"2005","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neulet.2015.04.002_bib0160","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.1074\/jbc.M707960200","article-title":"The CB2 cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis","volume":"283","author":"Palazuelos","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2015.04.002_bib0165","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.nurt.2009.08.002","article-title":"Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside","volume":"6","author":"Rahn","year":"2009","journal-title":"Neurother.: J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.neulet.2015.04.002_bib0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2042-6410-5-4","article-title":"Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus","volume":"5","author":"Rahn","year":"2014","journal-title":"Biol. Sex Diff."},{"key":"10.1016\/j.neulet.2015.04.002_bib0175","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.bjp.0702351","article-title":"Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630","volume":"126","author":"Ross","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0180","first-page":"859","article-title":"Cannabinoids in the treatment of pain and spasticity in multiple sclerosis","volume":"3","author":"Smith","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.neulet.2015.04.002_bib0185","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1073\/pnas.1017719108","article-title":"Tonic inhibition of chronic pain by neuropeptide Y","volume":"108","author":"Solway","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2015.04.002_bib0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","article-title":"Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial","volume":"329","author":"Svendsen","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.neulet.2015.04.002_bib0195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00415-012-6579-2","article-title":"A mechanism-based classification of pain in multiple sclerosis","volume":"260","author":"Truini","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pbb.2013.02.008","article-title":"Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy","volume":"105","author":"Vera","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2015.04.002_bib0205","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind randomizedplacebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neulet.2015.04.002_bib0210","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.neuroscience.2005.02.010","article-title":"Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain","volume":"132","author":"Walczak","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2015.04.002_bib0215","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00415-006-0218-8","article-title":"Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain: a double-blind placebo-controlled cross-over trial","volume":"253","author":"Wissel","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuroscience.2005.06.009","article-title":"Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons","volume":"135","author":"Wotherspoon","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2015.04.002_bib0225","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB2 receptors modulate cocaine\u2019s actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2015.04.002_bib0230","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2008.01.010","article-title":"Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain","volume":"583","author":"Yamamoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2\u00d77-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neulet.2015.04.002_bib0240","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/jnnp-2012-302468","article-title":"Multiple sclerosis and extract of cannabis: results of the MUSEC trial","volume":"83","author":"Zajicek","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2015.04.002_bib0245","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models","volume":"17","author":"Zhang","year":"2003","journal-title":"Eur. J. Neurosci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394015002736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394015002736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T18:24:02Z","timestamp":1537727042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394015002736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":49,"alternative-id":["S0304394015002736"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2015.04.002","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}